|
1.Bach SP, Renehan AG and Potten CS. (2000). Stem cells: the intestinal stem cell as a paradigm. Carcinogenesis 21:469-76. 2.Thomson JA, Itskovitz-Eldor J, Shapiro SS, Waknitz MA, Swiergiel JJ, Marshall VS and Jones JM. (1998). Embryonic stem cell lines derived from human blastocysts. Science 282:1145-7. 3.Gearhart J. (1998). New potential for human embryonic stem cells. Sience. 282:1061-2. 4.Pommey S and Galipeau J. (2006). The use of mesenchymal stromal cells in oncology and cell therapy. Bull Cancer. 93:901-7. 5.Steinwender C, Hofmann R, Kammler J, Kypta A, Pichler R, Maschek W, Schuster G, Gabriel C and Leisch F. (2006). Effects of peripheral blood stem cell mobilization with granulocyte-colony stimulating factor and their transcoronary transplantation after primary stent implantation for acute myocardial infarction. Am Heart J. 151:1296.e7-13. 6.Li J, Imitola J, Snyder EY and Sidman RL. (2006). Neural stem cells rescue nervous purkinje neurons by restoring molecular homeostasis of tissue plasminogen activator and downstream targets. J Neurosci. 26:7839-48. 7.Ferretti P, Mackay M and Walder S. (2006). The developing human spinal cord contains distinct populations of neural precursors. Neurodegener Dis. 3:38-44. 8.Laino G, Carinci F, Graziano A, d''Aquino R, Lanza V, De Rosa A, Gombos F, Caruso F, Guida L, Rullo R, Menditti D and Papaccio G. (2006). In vitro bone production using stem cells derived from human dental pulp.J Craniofac Surg. 17:511-5. 9.Margariti A, Zeng L and Xu Q. (2006). Stem cells, vascular smooth muscle cells and atherosclerosis.Histol Histopathol. 21:979-85. 10.Shi X and Garry DJ. (2006). Muscle stem cells in development, regeneration, and disease. Genes Dev. 20:1692-708. 11.Bickenbach JR, Stern MM, Grinnell KL, Manuel A and Chinnathambi S. (2006). Epidermal stem cells have the potential to assist in healing damaged tissues. J Invest Dermatol. 126 Suppl:118-23. 12.Potten CS and Ellis JR. (2006). Adult small intestinal stem cells: identification, location, characteristics, and clinical applications. Ernst Schering Res Found Workshop. 60:81-98. 13.Vascotto SG and Griffith M. (2006). Localization of candidate stem and progenitor cell markers within the human cornea, limbus, and bulbar conjunctiva in vivo and in cell culture. Anat Rec A Discov Mol Cell Evol Biol. 288:921-31. 14.Goureau O and Sahel JA. (2006). Retinal stem cells: mechanism of differentiation and therapeutic application. Pathol Biol. 54:64-71. 15.Fiegel HC, Lange C, Kneser U, Lambrecht W, Zander AR, Rogiers X and Kluth D. (2006). Fetal and adult liver stem cells for liver regeneration and tissue engineering. J Cell Mol Med. 10:577-87. 16.Di Gioacchino G, Di Campli C, Zocco MA, Piscaglia AC, Novi M, Santoro M, Santoliquido A, Flore R, Tondi P, Pola P, Gasbarrini G and Gasbarrini A. (2006). Transdifferentiation of stem cells in pancreatic cells: state of the art. Transplant Proc. 37:2662-3. 17.Lee HS, Huang GT, Chiang H, Chiou LL, Chen MH, Hsieh CH and Jiang CC. (2003). Multipotential mesenchymal stem cells from femoral bone marrow near the site of osteonecrosis. Stem Cells. 21:190-9. 18.Chan RJ and Yoder MC. (2004). The multiple facets of hematopoietic stem cells. Curr Neurovasc Res. 1:197-206. 19.Oyan B, Koc Y, Ozdemir E, Kars A, Turker A, Tekuzman G and Kansu E. (2006). High dose sequential chemotherapy and autologous stem cell transplantation in patients with relapsed/refractory lymphoma. Leuk Lymphoma. 47:1545-52. 20.El-Badri NS, Hakki A, Saporta S, Liang X, Madhusodanan S, Willing AE, Sanberg CD and Sanberg PR. (2006). Cord blood mesenchymal stem cells: potential use in neurological disorders. Stem Cells Dev. 15:497-506. 21.Zhang Y, Chai C, Jiang XS, Teoh SH and Leong KW. (2006). Co-culture of umbilical cord blood CD34+ cells with human mesenchymal stem cells. Tissue Eng. 12:2161-70. 22.Buzanska L, Jurga M, Stachowiak EK, Stachowiak MK and Domanska-Janik K. (2006). Neural stem-like cell line derived from a nonhematopoietic population of human umbilical cord blood. Stem Cells Dev. 15:391-406. 23.El-Badri NS. (2006). Cord blood stem cells: a fountain of youth for the brain. Stem Cells Dev. 15:293-4. 24.Schoemans H, Theunissen K, Maertens J, Boogaerts M, Verfaillie C and Wagner J. (2006). Adult umbilical cord blood transplantation: a comprehensive review. Bone Marrow Transplant. 38:83-93. 25.Caplan AI and Bruder SP. (2001). Mesenchymal stem cells: building blocks for molecular medicine in the 21st century. Trends Mol Med 7:259-64. 26.Minguell JJ, Erices A and Conget P. (2001). Mesenchymal stem cells. Exp Biol Med 226:507-20. 27.Woodbury D, Schwarz EJ, Prockop DJ and Black IB. (2000). Adult rat and human bone marrow stromal cells differentiate into neurons. J Neurosci Res 61:364-70. 28.Sanchez-Ramos J, Song S, Cardozo-Pelaez F, Hazzi C, Stedeford T, Willing A, Freeman TB, Saporta S, Janssen W, Patel N, Cooper DR and Sanberg PR. (2000). Adult bone marrow stromal cells differentiate into neural cells in vitro. Exp Neurol 164:247-56. 29.Deng W, Obrocka M, Fischer I and Prockop DJ. (2001). In vitro differentiation of human marrow stromal cells into early progenitors of neural cells by conditions that increase intracellular cyclic AMP. Biochem Biophys Res Commun 282:148-52. 30.Zuk PA, Zhu M, Ashjian P, De Ugarte DA, Huang JI, Mizuno H, Alfonso ZC, Fraser JK, Benhaim P and Hedrick MH. (2002). Human adipose tissue is a source of multipotent stem cells. Mol Biol Cell 13:4279-95. 31.Ashjian PH, Elbarbary AS, Edmonds B, DeUgarte D, Zhu M, Zuk PA, Lorenz HP, Benhaim P and Hedrick MH. (2003). In vitro differentiation of human processed lipoaspirate cells into early neural progenitors. Plast Reconstr Surg 111:1922-31. 32.Koc ON and Lazarus HM. (2001). Mesenchymal stem cells: heading into the clinic. Bone Marrow Transplant 2:235-39. 33.Studeny M, Marini FC, Champlin RE, Zompetta C, Fidler IJ and Andreeff M. (2002). Bone marrow-derived mesenchymal stem cells as vehicles for interferon-beta delivery into tumors. Cancer Res 62:3603-8. 34.Pittenger MF, Mackay AM, Beck SC, Jaiswal RK, Douglas R, Mosca JD, Moorman MA, Simonetti DW, Craig S and Marshak DR. (1999). Multilineage potential of adult human mesenchymal stem cells. Science 284:143-7. 35.Zuk PA, Zhu M, Mizuno H, Huang J, Futrell JW, Katz AJ, Benhaim P, Lorenz HP and Hedrick MH. (2001). Multilineage cells from human adipose tissue: implications for cell-based therapies. Tissue Eng 7:211-28. 36.Sottile V, Halleux C, Bassilana F, Keller H and Seuwen K. (2002). Stem cell characteristics of human trabecular bone-derived cells. Bone 30:699-704. 37.Erices A, Conget P and Minguell JJ. (2000). Mesenchymal progenitor cells in human umbilical cord blood. Br J Haematol 109:235-42. 38.Goodwin HS, Bicknese AR, Chien SN, Bogucki BD, Quinn CO and Wall DA. (2001). Multilineage differentiation activity by cells isolated from umbilical cord blood: expression of bone, fat, and neural markers. Biol Blood Marrow Transplant 7:581-8. 39.Lee OK, Kuo TK, Chen WM, Lee KD, Hsieh SL and Chen TH. (2004). Isolation of multipotent mesenchymal stem cells from umbilical cord blood. Blood 103:1669-75. 40.De Bari C, Dell''Accio F, Tylzanowski P and Luyten FP. (2001). Multipotent mesenchymal stem cells from adult human synovial membrane. Arthritis Rheum 44:1928-42. 41.Bruder SP, Jaiswal N and Haynesworth SE. (1997). Growth kinetics, self-renewal, and the osteogenic potential of purified human mesenchymal stem cells during extensive subcultivation and following cryopreservation. J Cell Biochem 64:278-94. 42.Linning KD, Tai MH, Madhukar BV, Chang CC, Reed DN, Sarah F, Trosko JE and Olson LK. (2004). Redox-mediated enrichment of self-renewing adult human pancreatic cells that possess endocrine differentiation potential. Pancrease 29:e64-e76. 43.Chang CC, Tsai JL, Kuo KK, Wang KH, Chiang CH, Kao AP, Tai MH and Trosko JE. (2004). Expression of Oct-4, alpha fetoprotein and vimentin, and lack of gap-junctional intercellular communication as common phenotypes for human adult liver stem cells and hepatoma cells. Proc Am Assoc Cancer Res 45: 642. 44.Smith J, Ladi E, Mayer-Proschel M and Noble M. (2000). Redox state is a central modulator of the balance between self-renewal and differentiation in a dividing glial precursor cell. Proc Natl Acad Sci USA 97:10032-7. 45.De Flora S, Izzotti A, D''Agostini F and Balansky RM. (2001). Mechanisms of N-acetylcysteine in the prevention of DNA damage and cancer, with special reference to smoking-related end-points. Carcinogenesis 22:999-1013. 46.Hata R and Senoo H. (1989). L-ascorbic acid 2-phosphate stimulates collagen accumulation, cell proliferation, and formation of a three-dimensional tissue like substance by skin fibroblasts. J Cell Physiol 138:8-16. 47.Chepda T, Cadau M, Girin P, Frey J and Chamson A. (2001). Monitoring of ascorbate at a constant rate in cell culture: effect on cell growth. In Vitro Cell Dev Biol Anim 37:26-30. 48.Studer L, Csete M, Lee SH, Kabbani N, Walikonis J, Wold B and McKay R. (2000). Enhanced proliferation, survival, and dopaminergic differentiation of CNS precursors in lowered oxygen. J Neurosci 20:7377-83. 49.El-Fouly MH, Trosko JE and Chang CC. (1987). Scrape-loading and dye transfer. A rapid and simple technique to study gap junctional intercellular communication. Exp Cell Res 168:422-0. 50.Trosko JE, Chang CC, Wilson MR, Upham B, Hayashi T and Wade M. (2000). Gap junctions and the regulation of cellular function of stem cells during development and differentiation. Methods 20:245-64. 51.Chang CC, Boezi JA, Warren ST, Sabourin CL, Liu PK, Glatzer L and Trosko JE. (1981). Isolation and characterization of a UV-sensitive hypermutable aphidicolin-resistant Chinese hamster cell line. Somatic Cell Genet 7:235-53. 52.Ezeh UI, Turek PJ, Reijo RA and Clark AT. (2005). Human embryonic stem cell genes OCT4, NANOG, STELLAR, and GDF3 are expressed in both seminoma and breast carcinoma. Cancer 104:2255-65. 53.Qu ZL, Zou SQ, Sun ZC, Wei GH, Wu XZ and Zhen SL. (2004). The expresseion and significance of human telomerase reverse transcriptase protein and gene in bile duct carcinomas and their adjacent tissue. Zhonghua Zhong Liu Za Zi 26:98-101. 54.Chang CC, Sun W, Cruz A, Saitoh M, Tai MH and Trosko JE. (2001). A human breast epithelial cell type with stem cell characteristics as target cells for carcinogenesis. Radiat Res 155:201-7. 55.Yamasaki H. (1990). Gap junctional intercellular communication and carcinogenesis. Carcinogenesis 11:1051-8. 56.Chang CC, Trosko JE, el-Fouly MH, Gibson-D''Ambrosio RE and D''Ambrosio SM. (1987). Contact insensitivity of a subpopulation of normal human fetal kidney epithelial cells and of human carcinoma cell lines. Cancer Res 47:1634-45. 57.Kao CY, Nomata K, Oakley CS, Welsch CW and Chang CC. (1995). Two types of normal human breast epithelial cells derived from reduction mammoplasty; phenotypic characterization and response to SV40 transfection. Carcinogenesis 16:531-8. 58.Matic M, Evans WH, Brink PR and Simon M. (2002). Epidermal stem cells do not communicate through gap junctions. J Invest Dermatol 118:110-6. 59.Grueterich M and Tseng SCG. (2002). Human limbal progenitor cells expanded on intact amniotic membrane ex vivo. Arch Ophthalmol 120:783-90. 60.Denker AE, Nicoll SB and Tuan RS. (1995). Formation of cartilage-like spheroids by micromass cultures of murine C3H10T1/2 cells upon treatment with transforming growth factor bets-1. Differentiation 59:25-34. 61.Rangappa S, Fen C, Lee EH, Bongso A and Eugene SKW. (2003). Transformation of adult mesenchymal stem cells isolated from the fatty tissue into cardiomyocytes. Ann Thorac Surg 75:775–9 62.Lee OK, Ko YC, Kuo TK, Chou SH, Li HJ, Chen WM, Chen TH and Su Y. (2004). Fluvastatin and lovastatin but not pravastatin induce neuroglial differentiation in human mesenchymal stem cells. J. Cell. Biochem 93: 917-28. 63.Akino K, Mineta T, Fukui M, Fujii T and Akita S. (2003). Bone morphogenetic protein-2 regulates proliferation of human mesenchymal stem cells. Wound Rep Reg 11:354-60. 64.Gronthos S, Franklin DM, Leddy HA, Robey PG, Storms RW and Gimble JM. (2001). Surface protein characterization of human adipose tissue-derived stromal cells. J Cell Physiol 189:54-63. 65.Wickham MQ, Erickson GR, Gimble JM, Vail TP and Guilak F. (2003). Multipotent stromal cells derived from the infrapatellar fat pad of the knee. Clin Orthop 412:196-212. 66.Rheinwald JG and Green H. (1975). Serial cultivation of strains of human epidermal keratinocytes; the formation of keratinizing colonies from singe cells. Cell 6:331-43. 67.Yuspa SH and Morgan DL. (1981). Mouse skin cells resistant to terminal differentiation associated with initiation of carcinogenesis. Nature 293:72-4. 68.Serakinci N, Guldberg P, Burns JS, Abdallah B, Schrodder H, Jensen T and Kassem M. (2004). Adult human mesenchymal stem cell as a target for neoplastic transformation. Oncogene 23:5095-8. 69.Zulewski H, Abraham EJ, Gerlach MJ, Daniel PB, Moritz W, Muller B, Vallejo M, Thomas MK and Habener JF. (2001). Multipotential nestin-positive stem cells isolated from adult pancreatic islets differentiate ex vivo into pancreatic endocrine, exocrine, and hepatic phenotypes. Diabetes 50:521-33. 70.Tang DG, Tokumoto YM, Apperly JA, Lloyd AC and Raff MC. (2001). Lack of replicative senescence in cultured rat oligodendrocyte precursor cells. Science 291:868-71. 71.Tai MH, Chang CC, Kiupel M, Webster, Olson LK and Trosko JE. (2005). Oct4 expression in adult human stem cells: evidence in support of the stem cell theory of carcinogenesis. Carcinogenesis 26:495-502. 72.Trosko JE, Tai MH, Chang CC, Olson LK, Lin TM and Madhukar BV. (2004). Expression of Oct-4 and lack of gap-junctional intercellular communication as “hallmarks” for human adult stem cells and cancer cells. Proc Am Asso Cancer Res 45:643.
73.AEnsenat-Waser R, Vicente-Salar A, Cigudosa JC, Roche E, Soria B and Reiq JA. (2006). Isolation and characterization of residual undifferentiated mouse embryonic stem cells from embryoid body cultures by fluorescence tracking.In vitro Cell Dev Biol Anim 42: 115-123.
74.Sell S. (2006). Potential gene therapy strategies for cancer stem cells. Curr Gene Ther 6: 579-591.
75.Redvers RP, Li A and Kaur P. (2006). Side population in adult murine epidermis exhibits phenotypic and functional characteristics of keratinocyte stem cells. Proc Nati Acad Sci USA 103: 13168-13173.
76.Moseley TA, Zhu M and Hedrick MH. (2006). Adipose-derived stem and progenitor cells as fillers in plastic and reconstructive surgery. Plast Reconstr Surg 118:121S-128S.
77.Gimble JM, Zvonic S, Flyd ZE, Kassem M and Nuttall ME. (2006). Playing with bone and fat. Cell Biochem 15:251-66.
78.Mehlhorn AT, Niemeyer P, Kaiser S, Finkenzeller G, Stark GB, Sudkamp NP and Schmal H. (2006). Differential Expression Pattern of Extracellular Matrix Molecules During Chondrogenesis of Mesenchymal Stem Cells from Bone Marrow and Adipose Tissue. Tissue Eng 12: 2853-2862.
79.Hanahan D and Weinberg RA. (2000). The hallmarks of cancer. Cell 100:57-70. 80.Martin GS. (2003). Cell signaling and cancer. Cancer Cell 4: 167-74. 81.Klein S and McCormick F and evitzki A. (2005). Killing time for cancer cells. Nature Rev. Cancer 5:573-80. 82.Sachs K and Perez O, Pe''er D, Lauffenburger DA and Nolan GP. (2005). Causal protein-signaling networks derived from multiparameter single-cell data. Science 308:523-9. 83.Lackner MR, Kindt RM, Carroll PM, Brown K, Cancilla MR, Chen C, deSilva H, Franke Y, Guan B, Heuer T, Hung T, Keegan K, Lee JM, Manne V, O’Brien C, Parry D, Perez-Villar JJ, Reddy RK, Xiao H, Zhan H, Cockett M, Plowman G Fitzgerald K, Costa M and Ross-Macdonald P. (2005). Chemical genetics identifies Rab geranylgeranyl transferase as an apoptotic target of farnesyl transferase inhibitors. Cancer Cell 7:325-36. 84.Buchdunger E, Cioffi CL, Law N, Stover D, Ohno-Jones S, Druker BJ and Lydon NB. (2000). Abl protein-tyrosine kinase inhibitor STI571 inhibits in vitro signal transduction mediated by c-kit and platelet-derived growth factor receptors. J. Pharmacol. Exp. Ther 295:139-145. 85.Weiss SW, Goldblum JR. Enzinger and Weiss. (2001). Soft tissue tumours. 4th ed. St. Louis (MO), Mosby, p. 641-93. 86.Kilpatrick SE, Doyon J, Choong PFM, et al. The clinicopathologic spectrum of myxoid and round cell liposarcoma: a study of 95 cases. Cancer 1996, 77, 1450-8. 87.Spillane AJ, Fisher C and Thomas JM. (1999). Myxoid liposarcoma-the frequency and the natural history of nonpulmonary soft tissue metastases. Ann Surg Oncol 6: 389-94. 88.Pearlstone DB, Pisters PW, Bold RJ, Feig BW, Hunt KK, Yasko AW, Patel S, Pollack A, Benjamin RS and Pollock RE. (1999). Patterns of recurrence in extremity liposarcoma: implications for staging and follow-up. Cancer 85:85-92. 89.Smith TA, Easley KA and Goldblum JR. (1996). Myxoid/round cell liposarcoma of the extremities. A clinicopathologic study of 29 cases with particular attention to extent of round cell liposarcoma. Am J Surg Pathol 20:171-80. 90.Knight JC, Renwick PJ, Clin PD, Van den Berghe H and Fletcher CD. (1995). Translocation t(12;16) (q13;p11) in myxoid liposarcoma and round cell liposarcoma: molecular and cytogenetic analysis. Cancer Res 55:24-27. 91.Lucas DR, Nascimento AG, Sanjay BK and Rock MG. (1994). Well-differentiated liposarcoma: the Mayo clinic experience with 58 patients. Am J Clin Pathol 102:677-83. 92.Henricks WH, Chu YC, Goldblum JR and Weiss SW. (1997). Dedifferentiated liposarcoma: a clinicopathological analysis of 155 cases with a proposal for an expanded definition of dedifferentiation. Am J Surg Pathol 21:271-81. 93.Rubin BP and Fletcher CDM. (1997). The cytogenetics of lipomatous tumours. Histopathology 30:507-11. 94.Downes KA, Goldblum JR, Montgomery EA and Fisher C. (2001). Pleomorphic liposarcoma: a clinicopathological analysis of 19 cases. Mod Pathol 14:179-84. 95.Patel SR, Burgess MA, Plager C and Papadopoulos NE, Linke KA and Benjamin RS. (1994). Myxoid liposarcoma –experience with chemotherapy. Cancer 74:1265-9. 96.Rohdewohld H, Weiher H, Reik W, Jaenisch R and Breindl M. (1987). Retrovirus integration and chromatin structure: Moloney murine leukemia proviral integration sites map near DNase I-hypersensitive sites. J. Virol 61:336-43. 97.Wu X, Li Y, Crise B, and Burgess SM. (2003). Transcription start regions in the human genome are favored targets for MLV integration. Science 300:1749-51. 98.Varmus HE, Padgett T, Heasley S, Simon G and Bishop J M (1977). Cellular functions are required for the synthesis and integration of avian sarcoma virus-specific DNA. Cell 11: 307-19. 99.Mitchell RS, Beitzel BF, Schroder AR, Shinn P, Chen H, Berry CC, Ecker JR and Bushman FD.(2004). Retroviral DNA integration: ASLV, HIV, and MLV show distinct target site preferences. PLoS Biol 2: E234. 100.Neil JC and Forrest, D. (1987). Mechanisms of retrovirus-induced leukaemia: selected aspects. Biochim. Biophys. Acta 907:71-91. 101.Hayward WS, Neel BG and Astrin SM. (1981). Activation of a cellular onc gene by promoter insertion in ALV-induced lymphoid leukosis. Nature 290:475-480. 102.Selten G, Cuypers HT, Zijlstra M, Melief C and Berns A. (1984). Involvement of c-myc in MuLV-induced T cell lymphomas in mice: frequency and mechanisms of activation. EMBO J 3:3215-22. 103.Kohn D B, Sadelain M, Dunbar C, Bodine D, Kiem HP, Candotti F, Tisdale J, Riviere I, Blau CA, Richard RE, Sorrentino B, Nolta J, Malech H, Brenner M, Cornetta K, Cavagnaro J, High K, Gloridoso J; American Society of Gene Therapy (ASGT) (2003). American Society of Gene Therapy (ASGT) ad hoc subcommittee on retroviral-mediated gene transfer to hematopoietic stem cells. Mol. Ther 8:180-7. 104.Li Z, Dullmann J, Schiedimeier B, Schmidt M, von Kalle C, Meyer J, Forster M, Stocking C, Wahlers A, Frank O, Ostertag W, Kuhlcke K, Eckert HG, Fehse B and Baum C. (2002). Murine leukemia induced by retroviral gene marking. Science 296:497. 105.Baum C, von Kalle C Staal FJ, Li Z, Fehse B, Schmidt M, Weerkamp F, Karisson S, Wagemaker G and Williams DA. (2004). Chance or necessity? Insertional mutagenesis in gene therapy and its consequences. Mol. Ther 9:5-13. 106.Drews J. (2000). Drug discovery: a historical perspective. Science 287:1960-4. 107.Lindsay MA. (2003). Target discovery. Nature Rev. Drug Discov 2:831-8. 108.Williams M. (2003). Target validation. Curr. Opin. Pharmacol 3:571-7. 109.López-Otín C and Overall CM. (2002). Protease degradomics: a new challenge for proteomics. Nature Rev. Mol. Cell Biol 3:509-19. 110.Coussens LM, Fingleton B and Matrisian LM. (2002). Matrix metalloproteinase inhibitors and cancer: trials and tribulations. Science 295:2387-92. 111.Fingleton B. (2003). Matrix metalloproteinase inhibitors for cancer therapy: the current situation and future prospects. Expert Opin. Ther. Targets 7:385-97. 112.Bergers G, Javaherian K, Lo KM, Folkman J and Hanahan D. (1999). Effects of angiogenesis inhibitors on multistage carcinogenesis in mice. Science 284:808-12. 113.Boehm T, Folkman J, Browder T and O''Reilly MS. (1997). Antiangiogenic therapy of experimental cancer does not induce acquired drug resistance. Nature 390:404-7. 114.Fingleton B, Vargo-Gogola T, Crawford HC and Matrisian LM. (2001). Matrilysin (MMP-7) expression selects for cells with reduced sensitivity to apoptosis. Neoplasia 3:459-68. 115.Balbin M, Fueyo A, Tester AM, Pendas AM, Pitiot AS, Astudillo A, Overall CM, Shapiro SD and Lopez-Otin C. (2003). Loss of collagenase-2 confers increased skin tumor susceptibility to male mice. Nature Genet 35:252-7. 116.D. Sulitzeanu. (1985) Human cancer-associated antigens: present status and implications for immunodiagnosis, in: G. Klein (Ed.), Advances in Cancer Research, vol. 44, Academic Press, Inc., New York, pp.1-42. 117.Garrett CT and Sell S. (1995). Cellular Cancer Markers, Humana Press, Totowa, NJ. 118.Gretzer MB and Partin AW. (2003). PSA markers in prostate cancer detection. Urol. Clin. North Am 30:677-86. 119.Crawford NP Colliver DW and Galandiuk S. (2003). Tumor markers and colorectal cancer: utility in management. J. Surg. Oncol 84: 239-48. 120.Cheung KL and Robertson FR. (2003). Objective measurement of remission and progression in metastatic breast cancer by the use of serum tumour markers. Minerva Chir 58:297-303. 121.Trompetas V, Panagopoulos E, Priovolou-Papaevangelou M and Ramantanis G. Giant benign true cyst of the spleen with high serum level of CA 19-9. Eur. J. Gastroenterol. Hepatol 14: 85-8. 122.Anderiesz C and Quinn MS. (2003). Screening for ovarian cancer. Med. J. Aust 178:655-6. 123.Sell S. (1980). Cancer Markers. Humana Press, Clifton, NJ. 124.Krebs EG and Beavo JA. (1979). Phosphorylation-dephosphorylation of enzymes. Annu. Rev. Biochem 48:923-59. 125.Beebe SJ and Corbin JD. (1986). Cyclic nucleotide-dependent protein kinases, in: E.G. Krebs, P.D. Boyer (Eds.), The Enzymes: Control by Phosphorylation, vol. 17, Academic Press, Orlando and London, pp. 43-111(Part A). 126.Lohmann SM and Walter U. (1984). Regulation of the cellular and subcellular concentrations and distribution of cyclic nucleotide-dependent protein kinases, in: P. Greengard, G.A. Robinson (Eds.), Advances in Cyclic Nucleotide and Protein Phosphorylation Research, vol. 18, Raven Press, New York, pp.63-117. 127.Cho YS, Park YG, Lee YN, Kim MK, Bates S, Tan L, Cho-Chung YS. (2000). Extracellular protein kinase A as a cancer biomarker: its expression by tumor cells and reversal by a myristate-lacking Calpha and RIIbeta subunit overexpression. Proc. Natl. Acad. Sci. U. S. A. 97:835-40. 128.Leor J, Patterson M, Quinones MJ, Kedes LH and Kloner RA. (1996). Transplantation of fetal myocardial tissue into the infarcted myocardium of rat: A potential method for repair of infarcted myocardium? Circulation 94 Suppl:II332-6. 129.Soonpaa MH, Koh GY, Klug MG and Field LJ. (1994). Formation of nascent intercalated discs between the grafted fetal cardiomyocytes and host myocardium. Science 264:98-101. 130.Li RK, Mickle DA, Weisel RD, Mohabeer MK, Zhang J, Rao V, Li G, Merante Fand Jia ZO. (1997). Natural history of fetal rat cardiomyocytes transplanted into adult rat myocardial scar tissue. Circulation 96:II179-87. 131.Scorsin M, Hagege AA, Dolizy I, Marotte F, Mirochnik N, Copin H, Barnoux M, le Bert M, Samuel JL RappaportL and Menasche P. (1998). Can cellular transplantation improve function in doxorubicin-induced heart failure? Circulation 98(Suppl 19):II151-6. 132.Watanabe E, Smith DM Jr, Delcarpio JB, Sun J, Smart FW, Van Meter CH Jr. and Claycomb WS. (1998). Cardiomyocyte transplantation in a porcine myocardial infarction model. Cell Transplantation 7:239-46. 133.Reinecke H, Zhang M, Bartosek T and Murry CE. (1999). Survival, integration, and differentiation of cardiomyocyte grafts: a study in normal and injured rat hearts. Circulation 100:193-202 134.Koh GY, Klug MG, Soonpaa MH and Field LJ. (1993). Differentiation and long-time survival of C2C12 myoblast grafts in heart. J Clin Invest 92:1548-54. 135.Taylor DA, Atkins BZ, Hungspreugs P, Jones TR, Reedy MC, Hutcheson KA, Glower DD and Kraus WE. (1998). Regenerating functional myocardium: improved performance after skeletal myoblast transplantation. Med Nature 4:929-33. 136.Yoo KJ, Li RK, Weisel RD, Mickle DA, Li G and Yau TM. (2000). Autologous smooth muscle cell transplantation improved heart function in dilated cardiomyopathy. Ann Thorac Surg 70:859-65. 137.Hutcheson KA, Atkins BZ, Hueman MT, Hopkins MB, Glower DD and Taylor DA. (2000). Comparison of benefits on myocardial performance of cellular cardiomyoplasty with skeletal myoblasts and fibroblasts. Cell Transplant 9:359-68. 138.Wang JS, Shum-Tim D, Galipeau J, Chedrawy E, Eliopoulos N and Chiu RC. (2000). Marrow stromal cells for cellular cardiomyoplasty: feasibility and potential clinical advantages. J Thorac Cardiovasc Surg 120:999-1005. 139.Tomita S, Li RK, Weisel RD, Mickle DA, Kim EJ Sakai T and Jia ZQ. (1999). Autologous transplantation of bone marrow cells improves damaged heart function. Circulation 100(Suppl 19):II247-56. 140.Constantinides PG, Taylor SM and Jones PA. (1978). Phenotypic conversion of cultured mouse embryo cells by Aza pyrimidine nucleosides. Dev Biol 66:5771. 141.Constantinides PG, Jones PA and Gevers W. (1977). Functional striated muscle cells from non-myoblast precursors following 5-azacytidine treatment. Nature 267:364-6. 142.Benedict WF, Banerjee A, Gardner A and Jones PA. (1977). Induction of morphological transformation in mouse C3H/10T1/2 clone 8 cells and chromosomal damage in hamster A (T1) C1-3 cells by cancer chemotherapeutic agents. Cancer Res 37(7 Pt 1):2202-8. 143.Makino S, Fukuda K, Miyoshi S, Konishi F, Kodama H, Pan J, Sano m, Takahashi T Hori S Abe H, Hata J, Umezawa A and Ogawa S. (1999). Cardiomyocytes can be generated from marrow stromal cells in vitro. Clin Invest 103:697-705. 144.Taylor SM and Jones PA. (1979). Multiple new phenotypes induced in 10T1/2 and 3T3 cells treated with 5-azacytidine. Cell 17:771-9. 145.Planat-Bénard V, Menard C, André M, Puceat M, Perez A, Garcia-Verdugo J-M, Pénicaud L and Casteilla, L. (2004). Spontaneous cardiomyocyte differentiation from adipose tissue stroma cells. Circ Res 94:223-9. 146.Pfeffer MA and Braunwald E. (1990). Ventricular remodeling after myocardial infarction: experimental observations and clinical implications. Circulation 1161-72. 147.Orlic D, Hill JM and Arai AE. (2002). Stem cells for myocardial regeneration. Circ Res 91:1092-102. 148.Condorelli G, Borello U, De Angelis L, Latronico M, Sirabella D, Coletta M, Galli R, Balconi G, Follenzi A, Frati G, Cusella De Angelis MG, Gioglio L, Amuchastegui S, Adorini L, Naldini L, Vescovi A, Dejana E and Cossu G. (2001). Cardiomyocytes induce endothelial cells to trans-differentiate into cardiac muscle: implications for myocardium regeneration. Proc Natl Acad Sci U S A 98:10733-8. 149.Jackson KA, Majka SM, Wang H, Pocius J, Hartley CJ, Majesky MW, Entman ML, Michael LH, Hirschi KK and Goodell MA. (2001). Regeneration of ischemic cardiac muscle and vascular endothelium by adult stem cells. J Clin Invest 107:1395-402. 150.Grounds MD, White JD, Rosenthal N and Bogoyevitch MA. (2002). The role of stem cells in skeletal and cardiac muscle repair. J Histochem Cytochem 50:589-610. 151.Makino S, Fukuda K, Miyoshi S, Konishi F, Kodama H, Pan J, Sano M, Takahashi T, Hori S, Abe H, Hata J, Umezawa A and Ogawa S. (1999). Cardiomyocytes can be generated from marrow stromal cells in vitro. J Clin Invest 103:697-705. 152.Orlic D, Kajstura J, Chimenti S, Jakoniuk I, Anderson SM, Li B, Pickel J, McKay R, Nadal-Ginard B, Bodine DM, Leri A and Anversa P. (2001). Bone marrow cells regenerate infarcted myocardium. Nature 410:701-5. 153.Gepstein L. (2002). Derivation and potential applications of human embryonic stem cells. Circ Res 91:866-76. 154.Rosen ED and Spiegelman BM. (2000). Molecular regulation of adipogenesis. Annu Rev Cell Dev Biol 16:145-71. 155.Erickson GR, Gimble JM, Franklin DM, Rice HE, Awad H and Guilak F. (2002). Chondrogenic potential of adipose tissue-derived stromal cells in vitro and in vivo. Biochem Biophys Res Commun 290:763-9. 156.Safford KM, Hicok KC, Safford SD, Halvorsen YD, Wilkison WO, Gimble JM and Rice HE. (2002). Neurogenic differentiation of murine and human adipose-derived stromal cells. Biochem Biophys Res Commun 294:371-9. 157.Cousin B, André M, Arnaud E, Pénicaud L and Casteilla L. (2003). Reconstitution of lethally irradiated mice by cells isolated from adipose tissue. Biochem Biophys Res Commun 301:1016-22. 158.Nakahara H, Dennis JE, Bruder SP, Haynesworth SE, Lennon DP and Caplan AI. (1991). In vitro differentiation of bone and hypertrophic cartilage from periosteal-derived cells. Exp Cell Res 195:492-503. 159.Nakahara H, Goldberg VM and Caplan AI. (1991). Culture-expanded human periosteal-derived cells exhibit osteochondral potential in vivo. J Orthop Res 9:465-76. 160.Claycomb WC and Palazzo MC. (1980). Culture of the terminally differentiated adult cardiac muscle cell: a light and scanning electron microscope study. Dev Biol 80:466-82. 161.Sugaya K, Alvarez A, Marutle A, Kwak YD and Choumkina E. (2006). Stem cell strategies for Alzheimer''s disease therapy. Panminerva Med 48:87-96. 162.Miller RH. (2006). The promise of stem cells for neural repair. Brain Res 26:258-64. 163.Fallon J, Reid S, Kinyamu R, Opole I, Opole R, Baratta J, Korc M, Endo TL, Duong A, Nguyen G, Karkehabadhi M, Twardzik D, Patel S and Loughlin S.( 2000). In vivo induction ofmassive proliferation, directed migration, and differentiation of neural cells in the adult mammalian brain. Proc. Natl. Acad. Sci. U. S. A. 97:14686-91. 164.Nakatsuji Y and Miller RH. (2001). Selective cell-cycle arrest and induction of apoptosis in proliferating neural cells by ganglioside GM3. Exp. Neurol 168:290-9. 165.Alvarez-Buylla A, Garcia-Verdugo JM and Tramontin AD. (2001). A unified hypothesis on the lineage of neural stem cells. Nat. Rev., Neurosci 2:287-93. 166.Bambakidis NC and Miller RH. (2004). Transplantation of oligodendrocyte precursors and sonic hedgehog results in improved function and white matter sparing in the spinal cords of adult rats after contusion. Spine J 4:16-26. 167.Benraiss A, Chmielnicki E, Lerner K, Roh D and Goldman, SA. (2001). Adenoviral brain-derived neurotrophic factor induces both neostriatal and olfactory neuronal recruitment from endogenous progenitor cells in the adult forebrain. J. Neurosci 21:6718-31. 168.Bjornson CR, Rietze RL, Reynolds BA, Magli MC, Vescovi AL. (1999). Turning brain into blood: a hematopoietic fate adopted by adult neural stem cells in vivo. Science 283:534-7. 169.Bottai D, Fiocco R, Gelain F, Defilippis L, Galli R, Gritti A and Vescovi LA. (2003). Neural stem cells in the adult nervous system. J. Hematother. Stem Cell Res 12:655-70. 170.Calza L, Giuliani A, Fernandez M, Pirondi S, D''Intino G, Aloe L and Giardino L.(2003). Neural stem cells and cholinergic neurons: regulation by immunolesion and treatment with mitogens, retinoic acid, and nerve growth factor. Proc. Natl. Acad. Sci. U. S. A. 100:7325-30. 171.Craig CG, Tropepe V, Morshead CM, Reynolds BA, Weiss S, van der Kooy D. (1996). In vivo growth factor expansion of endogenous subependymal neural precursor cell populations in the adult mouse brain. J. Neurosci 16:2649-58. 172.Fallon J, Reid S, Kinyamu R, Opole I, Opole R, Baratta J, Korc M, Endo TL, Duong A, Nguyen G, Karkehabadhi M, Twardzik D, Patel S and Loughlin S. (2000). In vivo induction of massive proliferation, directed migration, and differentiation of neural cells in the adult mammalian brain. Proc. Natl. Acad. Sci. U. S. A. 97:14686-91. 173.Gage FH. (2000). Mammalian neural stem cells. Science 287:1433-8. 174.Gage FH, Coates PW, Palmer TD, Kuhn HG, Fisher LJ, Suhonen JO, Peterson DA, Suhr ST and Ray J. (1995). Survival and differentiation of adult neuronal progenitor cells transplanted to the adult brain. Proc. Natl. Acad. Sci. U. S. A. 92:11879-83. 175.Inoue M, Honmou O, Oka S, Houkin K, Hashi K, Kocsis JD. (2003). Comparative analysis of remyelinating potential of focal and intravenous administration of autologous bone marrow cells into the rat demyelinated spinal cord. Glia 44:111-8. 176.Sanchez-Ramos J, Song S, Cardozo-Pelaez F, Hazzi C, Stedeford T Willing A, Freeman TB, Saporta S, Janssen W, Patel N, Cooper DR and Sanberg PR. (2000). Adult bone marrow stromal cells differentiate into neural cells in vitro. Exp. Neurol 164:247-56. 177.Toda H, Takahashi J, Mizoguchi A, Koyano K and Hashimoto N. (2000). Neurons generated from adult rat hippocampal stem cells form functional glutamatergic and GABAergic synapses in vitro. Exp. Neurol 165:66-76. 178.Tropepe V, Craig CG, Morshead CM and van der Kooy D. (1997). Transforming growth factor-alpha null and senescent mice show decreased neural progenitor cell proliferation in the forebrain subependyma. J. Neurosci 17:7850-9.
|